Collectively, this evidence strongly indicates that the SIRT7-AKT axis could serve as a pivotal signaling cascade underpinning the advantageous outcomes of tailored dietary regimens in combination with chemotherapy for breast cancer. This evidence concerns the gene AKT1 and breast carcinoma.